Subungual hyperkeratosis is an uncommon skin condition that affects the nails. It is characterized by thickening of the nail plate and can cause discoloration, splitting, and brittleness of the nail. It is a benign condition, but it can cause discomfort and embarrassment to those affected. In this article, we will take a closer look at subungual hyperkeratosis, its causes, symptoms, and available treatments.
Subungual hyperkeratosis is a disorder of the nails that causes them to become thickened and discolored. It is caused by an overgrowth of the nail plate, which is the hard, protective layer of the nail. This overgrowth can lead to a variety of symptoms, such as discoloration, splitting, and brittleness of the nail. It can also cause the nail to become painful and tender, and it can lead to an infection of the nail bed.
The exact cause of subungual hyperkeratosis is unknown, but there are several factors that may contribute to its development. These include: • Trauma or injury to the nail • Fungal or bacterial infection • Psoriasis • Systemic diseases, such as diabetes or lupus • Excessive use of nail polish or other cosmetic products • Vitamin deficiency
The most common symptom of subungual hyperkeratosis is thickening of the nail plate. This can lead to discoloration, splitting, and brittleness of the nail. Other symptoms may include: • Pain and tenderness • Swelling • Redness • Crumbling of the nail • Infection of the nail bed
Subungual hyperkeratosis can be diagnosed by a doctor through a physical examination of the affected nails. The doctor may also take a sample of the nail to be analyzed in a laboratory. The treatment for subungual hyperkeratosis depends on the underlying cause. If the condition is caused by a fungal or bacterial infection, antifungal or antibiotic medications may be prescribed. If the condition is caused by psoriasis, topical corticosteroids may be recommended. Vitamin deficiencies may be treated with supplements. In some cases, surgery may be needed to remove the affected nail.
The best way to prevent subungual hyperkeratosis is to take good care of your nails. This includes avoiding trauma or injury to the nail, avoiding excessive use of nail polish or other cosmetic products, and maintaining good hygiene. It is also important to keep your nails well-trimmed and to avoid picking at them.
Subungual hyperkeratosis is an uncommon skin condition that affects the nails. It is characterized by thickening of the nail plate and can cause discoloration, splitting, and brittleness of the nail. The exact cause of subungual hyperkeratosis is unknown, but there are several factors that may contribute to its development. The most common symptom is thickening of the nail plate. The treatment for subungual hyperkeratosis depends on the underlying cause. The best way to prevent subungual hyperkeratosis is to take good care of your nails and maintain good hygiene.
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation